Michèle joined the Index Life Sciences Team as a Partner in 2006. Michele's invested and sits on the board of a number of Index Life Science portfolio companies including Epsilon 3 Bio, FunXional Therapeutics, LinguaFlex, Minerva Neurosciences and OncoEthix. She was also a Director at Aegerion. Prior to joining Index, Michele was Investment Director at EDRIP (Edmond de Rothschild Investment Partner) in Paris for three years. Before she spent more than 15 years in several development and marketing positions at Sanofi International, BMS, RPR/Aventis international and Serono International, her experience spans over different therapeutic areas as CNS, cardiovascular, oncology and reproductive health.
- Grew up:
- Paris, France
- Paris, Pensylvania (US), Geneva (Swiss)